Chemours Co (Chemours) provides titanium technologies, fluoro products, and chemical solutions. The company offers industrial and specialty chemical products for markets such as refrigeration and air conditioning, paints and coatings, plastics, transportation, semiconductor and consumer electronics, general industrial, and oil and gas.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Chemours leverages its state-of-the-art R&D facility, the Chemours Discovery Hub, to drive faster product development on a global scale. The company's R&D initiatives focus on the discovery and development of new products, enhancement of existing products, and regulatory approval of new and existing products. The company strategically invests in high-return, low-risk initiatives across its portfolio, prioritizing expansion into rapidly growing end-markets, such as data center cooling, next-generation refrigerants, and semiconductor fabrication. The company is committed to sustainable innovation and growth, designing sustainable offerings that perform at the highest level while minimizing environmental impact. The Chemours Discovery Hub is the primary R&D unit of Chemours. It is a 312,000-square-foot R&D center located on the Science, Technology, and Advanced Research campus of the University of Delaware in Newark, Delaware. The unit is responsible for managing the company's R&D activities, driving faster product development, and supporting the company's innovation and technical expertise. As of December 31, 2025, Chemours owned approximately 3,892 granted patents and 1,757 pending applications in the US and internationally. The company also held approximately 1,667 trademark registrations and 12 pending trademark applications. In FY2025, it spent US$108 million on R&D, which as a percentage of revenue, stood at 1.9% and declined 0.9% YoY.